This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Ucl Business Plc, Vitaflo International Ltd, Vitaflow (International) Ltd. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 301 
2 out of 2 
1 out of 1 Years Active: 2022-2025
Title: Simon Eaton - Innovator in Dietary Therapies
Introduction
Simon Eaton is a notable inventor based in London, GB. He has made significant contributions to the field of dietary therapies, particularly in relation to mitochondrial dysfunction and epilepsy. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
Eaton's latest patents include a nutritional product aimed at treating disorders associated with mitochondrial dysfunction, including epilepsy. Another significant patent is a composition designed for the treatment of epilepsy, which comprises a decanoic acid to octanoic acid ratio of 70:30 to 90:10 wt/wt. These innovations reflect his commitment to advancing therapeutic options for individuals suffering from these conditions.
Career Highlights
Throughout his career, Simon Eaton has worked with reputable companies such as UCL Business Plc and Vitaflo International Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of dietary therapies.
Collaborations
Eaton has collaborated with esteemed professionals in his field, including Simon Heales and Patricia Rutherford. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
In summary, Simon Eaton is a dedicated inventor whose work in dietary therapies has the potential to make a significant impact on the treatment of epilepsy and related disorders. His innovative patents and collaborations highlight his commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile